Literature DB >> 18781895

Prostatic tumor stroma: a key player in cancer progression.

R A Taylor1, G P Risbridger.   

Abstract

Although it is evident that prostatic epithelial stem cells are responsible for maintaining normal and malignant tissues, it is well recognized that epithelial cells do not exist independently, but act in concert with the stromal microenvironment. Prostatic stroma is pivotal for normal development and homeostasis. The genetic and morphological changes that occur in prostatic epithelial cells, as they progress from a normal to malignant phenotype, have been well described. However, it is evident that the surrounding microenvironment also plays a major role in cancer cell growth, survival, invasion and metastatic progression. Prostatic tumor stroma provides a niche environment for cancer stem cells and therefore contributes to self-renewal and differentiation. In order to target the tumor microenvironment and develop new therapeutics for prostate cancer, we must understand the role of the tumor stroma, specifically the events mediating the interactions between the cancer stem cell and its immediate microenvironment during cancer initiation and progression. This article presents the rationale and discusses the challenges to targeting prostatic tumor stroma in cancer therapies that will potentially treat prostate cancer.

Entities:  

Mesh:

Year:  2008        PMID: 18781895     DOI: 10.2174/156800908785699351

Source DB:  PubMed          Journal:  Curr Cancer Drug Targets        ISSN: 1568-0096            Impact factor:   3.428


  25 in total

1.  Cancer-associated fibroblasts derived from EGFR-TKI-resistant tumors reverse EGFR pathway inhibition by EGFR-TKIs.

Authors:  Sheldon R Mink; Surabhi Vashistha; Wenxuan Zhang; Amanda Hodge; David B Agus; Anjali Jain
Journal:  Mol Cancer Res       Date:  2010-06-08       Impact factor: 5.852

Review 2.  Future directions in the field of endometrial cancer research: the need to investigate the tumor microenvironment.

Authors:  A S Felix; J Weissfeld; R Edwards; F Linkov
Journal:  Eur J Gynaecol Oncol       Date:  2010       Impact factor: 0.196

3.  Cells Comprising the Prostate Cancer Microenvironment Lack Recurrent Clonal Somatic Genomic Aberrations.

Authors:  Daniella Bianchi-Frias; Ryan Basom; Jeffrey J Delrow; Ilsa M Coleman; Olga Dakhova; Xiaoyu Qu; Min Fang; Omar E Franco; Nolan G Ericson; Jason H Bielas; Simon W Hayward; Lawrence True; Colm Morrissey; Lisha Brown; Neil A Bhowmick; David Rowley; Michael Ittmann; Peter S Nelson
Journal:  Mol Cancer Res       Date:  2016-01-11       Impact factor: 5.852

Review 4.  Human prostate cancer heterotransplants: a review on this experimental model.

Authors:  Lluis A Lopez-Barcons
Journal:  Asian J Androl       Date:  2010-04-05       Impact factor: 3.285

Review 5.  Breast and prostate cancer: more similar than different.

Authors:  Gail P Risbridger; Ian D Davis; Stephen N Birrell; Wayne D Tilley
Journal:  Nat Rev Cancer       Date:  2010-02-11       Impact factor: 60.716

Review 6.  Small-cell neuroendocrine carcinoma of the prostate: are heterotransplants a better experimental model?

Authors:  Lluis-A Lopez-Barcons
Journal:  Asian J Androl       Date:  2009-12-21       Impact factor: 3.285

Review 7.  Illuminating the chemistry of life: design, synthesis, and applications of "caged" and related photoresponsive compounds.

Authors:  Hsien-Ming Lee; Daniel R Larson; David S Lawrence
Journal:  ACS Chem Biol       Date:  2009-06-19       Impact factor: 5.100

Review 8.  Starving the addiction: new opportunities for durable suppression of AR signaling in prostate cancer.

Authors:  Karen E Knudsen; Howard I Scher
Journal:  Clin Cancer Res       Date:  2009-07-28       Impact factor: 12.531

9.  Androgen regulation of epithelial-mesenchymal transition in prostate tumorigenesis.

Authors:  Emily A Matuszak; Natasha Kyprianou
Journal:  Expert Rev Endocrinol Metab       Date:  2011-05

10.  Enhanced expression of SOS1 is detected in prostate cancer epithelial cells from African-American men.

Authors:  Olga A Timofeeva; Xueping Zhang; Habtom W Ressom; Rency S Varghese; Bhaskar V S Kallakury; Kan Wang; Youngmi Ji; Amrita Cheema; Mira Jung; Milton L Brown; Johng S Rhim; Anatoly Dritschilo
Journal:  Int J Oncol       Date:  2009-10       Impact factor: 5.650

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.